Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Clin Endocrinol (Oxf) ; 85(5): 764-771, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27219465

RESUMO

BACKGROUND: Although oral contraceptives (OCs) are one the most widespread therapy in young polycystic ovary syndrome (PCOS) women and physical exercise represents a crucial first step in the treatment of overweight and obese PCOS, no studies were performed to compare the effects on cardiovascular risk (CVR) of OCs and physical exercise in PCOS. OBJECTIVE: To compare the effects of OCs administration and physical exercise on the CVR, clinical, hormonal and metabolic parameters in PCOS women. METHODS: One hundred and fifty PCOS women were enrolled and were randomized to OCs (3 mg drospirenone plus 30 µg ethinyloestradiol), structured exercise training programme (SETP) or polyvitamin tablets. The intervention phase study was of 6 months. Primary outcome was intima-media thickness (IMT) and flow-mediated dilation (FMD). Secondary outcomes were clinical, hormonal and metabolic changes. RESULTS: A significant reduction of IMT and a significant increase of FMD were observed in the SETP group after treatment. Compared to baseline, in the SETP group, a significant improvement in anthropometric measures, insulin sensitivity indexes, lipid profile, cardiopulmonary function, inflammatory markers and frequency of menses was observed. Oral contraceptives use was associated with a significant decrease of hyperandrogenism and a significant improvement of frequency of menses. Further, OCs use had a neutral effect on CVR risk factors. CONCLUSION: OCs effectively treat hyperandrogenism and menstrual disturbances, while SETP is more effective in improving cardiometabolic profile and cardiopulmonary function in PCOS.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Anticoncepcionais Orais/farmacologia , Exercício Físico/fisiologia , Doenças Metabólicas/prevenção & controle , Síndrome do Ovário Policístico/terapia , Adulto , Androstenos/administração & dosagem , Androstenos/uso terapêutico , Doenças Cardiovasculares/patologia , Doenças Cardiovasculares/terapia , Espessura Intima-Media Carotídea , Anticoncepcionais Orais/uso terapêutico , Etinilestradiol/administração & dosagem , Etinilestradiol/uso terapêutico , Feminino , Humanos , Hiperandrogenismo/tratamento farmacológico , Doenças Metabólicas/terapia , Fatores de Risco , Adulto Jovem
2.
Minerva Endocrinol ; 2014 Dec 17.
Artigo em Inglês | MEDLINE | ID: mdl-25517402

RESUMO

Adulthood and childhood obesity is rapidly becoming an epidemic problem and it has a short and long term impact on health. Short term consequences are mostly represented by psychological effects, in fact obese children have more chances to develop psychological or psychiatric problems than non--obese children. The main long term effect is represented by the fact that childhood obesity continues into adulthood obesity and this results in negative effects in young adult life, since obesity increases the risk to develop morbidity and premature mortality. The obesity--related diseases are mostly represented by hypertension, type 2 diabetes, dyslipidaemia, cardiovascular diseases. Medical treatment should be discouraged in childhood because of the side effects and it should be only reserved for obese children with related medical complications. Lifestyle changes should be encouraged in both adulthood and childhood obesity. This review focuses on the management of obesity both in adulthood and in childhood, paying particular attention to lifestyle changes that should be recommended.

3.
Minerva Cardioangiol ; 59(2): 121-6, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21242949

RESUMO

AIM: Cardiovascular disease is a leading cause of morbidity and mortality in end-stage renal disease (ESRD) patients on maintenance hemodialysis (HD). Neither traditional nor emerging risk factors for cardiovascular disease can explain completely this excess of morbidity and mortality and the role and timing of primary prevention strategies in this population has not been clarified. The aim of this study was to assess if an aggressive pharmacological preventive treatment may reduce the myocardial ischemic burden and then improve the cardiovascular outcome In ESRD patients. METHODS: Forty-three asymptomatic ESRD patients on maintenance HD were evaluated. Asymptomatic patients with neither history nor clinical evidence of cardiovascular disease were considered. A total of 31 ESRD patients were enrolled into the study and were submitted to Tc-99m SESTAMIBI myocardial gated- single-photon emission computed tomography (SPECT) stress test. All patients then received an aggressive medical regimen with statins, antiplatelet drugs, ACE inhibitors (ACE-I) and/or Angiotensin II Receptor Blockers (ARB) and other hypotensive, glucose-lowering medications, sevelamer, calcium carbonate and calcitriol if required. RESULTS: A significant reduction of coronary functional reserve was found in more than 50% of otherwise asymptomatic HD patients and may often be reverted by prolonged aggressive medical therapy. After a four-year follow-up under aggressive medical therapy no significant difference was observed neither in the incidence of conventional and emerging cardiovascular risk factors nor in cardiovascular outcome of patients with or without silent myocardial ischemia (SMI). CONCLUSION: As cardiovascular disease (CVD) is by far the first cause of death in ESRD, an aggressive medical management may be highly advisable for the primary prevention of major adverse cardiac events in all HD patients despite the stress test evidence of inducible myocardial ischemia .


Assuntos
Doenças Cardiovasculares/etiologia , Falência Renal Crônica/complicações , Falência Renal Crônica/terapia , Diálise Renal , Doenças Assintomáticas , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo
4.
Clin Ter ; 160(1): 11-5, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19290406

RESUMO

OBJECTIVES: Cardiovascular disease (CVD) is the main cause of death among haemodialysis (HD) patients. Emerging cardiovascular risk factors such as oxidative stress and chronic inflammation are involved in these patients together with traditional risk factors. Here we investigate the effects of a short-term folate treatment on some markers of chronic inflammation in two groups of HD patients with and without vascular occlusive disease (VOD). PATIENTS AND METHODS: Homocysteine (HCy), C-reactive protein (CRP), Folate, fibrinogen and alpha1 acid glycoprotein (alpha1AGP) were dosed before and after a 3-month course of high-dose folate (25 mg intravenous calcium laevofolinate pentahydride once weekly) and again after a one-month washout in 15 HD patients with established VOD (group A) and in 15 comparable HD patients with no diagnosis of VOD (group B). RESULTS: Baseline HCy and CRP were significantly elevated in patients of both groups A and B compared to normal values. Folate treatment significantly reduced HCy in patients of both groups A and B and alpha1AGP only in patients of group A, while the other markers were not modified. After the one-month washout a significant raise of CRP could be observed in patients of group A; again, the other markers were not modified. CONCLUSIONS: Our results suggest that significant reduction of serum HCy can be achieved in both patients with or without VOD after administration of high-dose folic acid. Hence, folic acid supply is useful in the treatment of hyperhomocysteinemia in HD patients, although it is not sufficient to modify their chronic inflammatory status.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Ácido Fólico/uso terapêutico , Hiper-Homocisteinemia/tratamento farmacológico , Diálise Renal , Complexo Vitamínico B/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças Cardiovasculares/etiologia , Feminino , Humanos , Hiper-Homocisteinemia/complicações , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Doenças Vasculares/complicações
5.
Minerva Ginecol ; 54(5): 443-5, 2002 Oct.
Artigo em Italiano | MEDLINE | ID: mdl-12364891

RESUMO

Lesions of the abdominal vessels are becoming more frequent owing to the increase in the number of laparoscopies carried out with trochars: they occur in fact in 2% of cases. A study has been carried out to compare the effectiveness of 2 methods for stopping haemorrhage: the use of a Foley catheter and suturing with a Reverdin needle. Abdominal haemorrhages take place as a result of lesions during introduction of accessory trochars in the superficial, circumflex and deep epigastric vessels. Six patients were treated with Foley's catheter while 13 were treated with Reverdin's needle under visual control, maintaining the same operative route, something that is not possible with the Foley catheter. Patients treated with suturing were discharged within 24 hours without irritation or pain.


Assuntos
Cateterismo , Hemorragia Pós-Operatória/prevenção & controle , Instrumentos Cirúrgicos/efeitos adversos , Suturas , Parede Abdominal , Humanos
6.
Clin Ter ; 143(5): 375-82, 1993 Nov.
Artigo em Italiano | MEDLINE | ID: mdl-8275653

RESUMO

Significant signs of uremic osteodystrophy were found at Rx examination of the pelvis in 29 out of 72 uremic patients (40%) undergoing maintenance hemodialysis. It is therefore thought that Rx of the pelvis, although it is more significant for some signs (brown tumors, alterations of the trabecular structure, enlargement of Ward's triangle) than for others, such as subperiosteal resorption, should not be neglected in these patients.


Assuntos
Falência Renal Crônica/terapia , Pelve/diagnóstico por imagem , Diálise Renal/efeitos adversos , Uremia/terapia , Adolescente , Adulto , Idoso , Doenças Ósseas/diagnóstico por imagem , Neoplasias Ósseas/diagnóstico por imagem , Doença Crônica , Feminino , Glomerulonefrite/complicações , Humanos , Falência Renal Crônica/complicações , Falência Renal Crônica/etiologia , Masculino , Pessoa de Meia-Idade , Radiografia , Assistência Terminal , Uremia/complicações , Uremia/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA